↓ Skip to main content

Risperidone dose for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, October 2009
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risperidone dose for schizophrenia
Published in
Cochrane database of systematic reviews, October 2009
DOI 10.1002/14651858.cd007474.pub2
Pubmed ID
Authors

Chunbo Li, Jun Xia, Jijun Wang

Abstract

Risperidone is a widely used antipsychotic drug for people with schizophrenia. It is important to get a balance between gaining the most positive effects for the least negative outcomes. The optimal dose of risperidone is the focus of this review.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 50%
Student > Doctoral Student 1 25%
Unspecified 1 25%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 50%
Unspecified 1 25%
Psychology 1 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2016.
All research outputs
#6,353,155
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#6,588
of 8,923 outputs
Outputs of similar age
#48,702
of 118,699 outputs
Outputs of similar age from Cochrane database of systematic reviews
#66
of 98 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 48th percentile – i.e., 48% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 118,699 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.